Skip to content
Screener

Turn Therapeutics Inc. TTRX Q4 2025 Annual earnings

Reported March 31, 2026 · Before market open

EPS-$0.09Miss by $0.04
EPS estimate-$0.05

Next report

Nov 12, 2026 (in 2 months)
EPS estimate-$0.09

Financials

Q4 2025

Income statement

See full
Operating income-$2.2M-567%

Balance sheet

See full
Cash & equivalents$5.1M+482%
Total debt$80.4K-33.6%
Total equity$4.7M+2,741%
Total assets$12.2M+494%

Cash flow

See full
Operating cash flow-$1.2M-173%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$116.01M—
Enterprise value$111.02M—

Returns & leverage

See full
Debt / equity0×—
Current ratio0.9×-0.7×

Versus estimates

Diluted EPS

Q2 2026-$0.20Miss by $0.18Q1 2026-$0.03Miss by $0.01
Q4 2025-$0.09Miss by $0.04
Q3 2025-$0.07

FAQ

When did Turn Therapeutics Inc. report Q4 2025 earnings?
Turn Therapeutics Inc. (TTRX) reported Q4 2025 earnings on March 31, 2026 before market open.
What were Turn Therapeutics Inc.'s Q4 2025 revenue and EPS?
Turn Therapeutics Inc. reported eps of $-0.09 for Q4 2025.
Did Turn Therapeutics Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.05 by $0.04.
Where can I find Turn Therapeutics Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001213900-26-037470) and the 10-K periodic report (0001213900-26-037505) directly on SEC EDGAR. The filing index links above go to sec.gov.